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Stimulation of endothelial adenosine Al receptors 
enhances adhesion of neutrophils in the intact guinea 
pig coronary system 
S Zahler, B F Becker, P Raschke, and E Gerlach 
Objective: The primary aim was to determine the action of pathophysiologically relevant adenosine 
concentrations (0.1- 1 p M )  on adhesion of neutrophils to coronary endothelium. Further aims were to evaluate 
the nature and localisation of the adenosine receptor involved. and to assess the effect of endogenous adenosine. 
Methods: Adhesion was studied in isolated perfused guinea pig hearts by determining the number of cells 
emerging in the coronary effluent after intracoronary bolus injections of 600 000 neutrophils prepared from 
guinea pig or human blood. The system was characterised by the use of the proadhesive stimulus thrombin. 
Results: A 5 rnin infusion of adenosine (0.1-0.3 p M )  or the A, receptor agonist Nh-cyclopentyladenosine (CPA, 
0.01 p M )  significantly increased adhesion from about 208 (control) to 30%. This effect was prevented by the 
A, receptor antagonist dipropyl-8-cyclopentylxanthine (DPCPX. 0.1 pM). It was not diminished by cessation of 
adenosine infusion 90 s prior to neutrophil injection. At a higher concentration of adenosine (1  pM), adhesion 
did not seem to be enhanced. However, coinfusion of the A2 receptor antagonist 3,7-dimethyl- 1 -propargylxanthine 
(DMPX. 0.1 pM) with 1 IJ.M adenosine unmasked the A ,  action, adhesion rising to 39%. Adenosine had a 
quantitatively identical effect on adhesion of human neutrophils. Total ischaemia of 15 min duration raised 
adhesion of subsequently applied neutrophils to 35%. This effect was completely blocked by DPCPX, as well 
as by ischaeniic preconditioning (3 X 3 min). Preconditioning raised initial postischaemic coronary effluent 
adenosine from about 0.8 IJ.M to 1 .5 pM. Conclusions: The findings suggest a bimodal participation of adenosine 
i n  the development of postischaemic dysfunction by an endothelium dependent modulation of neutrophil 
adhesion. Stimulation occurs via endothelial A, receptors at submicromolar adenosine levels, whereas cardio- 
protection by adenosine may in part relate to the use of pharmacologically high concentrations of adenosine or 
enhanced endogenous production after preconditioning. 
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dhesion of polymorphonuclear neutrophils to the 
vascular endothelium is a crucial event in inflam- A mation and reperfusion injury.' ' The nature of the 
mediators involved in the case of cardiac reperfusion 
remains uncertain. Adenosine. which is produced by 
i s  reported to have anti-inflammatory and 
after ischaemia when applied at concen- 
trations of more than 1 F M . ~  'However. the concentrations 
detected in coronary venous blood under circumstances 
such as coronary insufficiency or percutaneous transluminal 
coronary angioplasty (PTCA) range between 0.1 and 
1 pM.' Moreover. i n  a recent study by our group. 
adenosine (0.1 to 0.2 pM) was found to be essential for 
inducing reperfusion damage by neutrophils in an isolated 
working heart preparation.' 
In an attempt to resolve this discrepancy. the role of 
adenosine in neutrophil adhesion to intact coronary endo- 
thelium was examined at concentrations of 0.1 to 1 p,M. 
Since a strong influence of shear stress on adhesive cell - 
cell interactions has become evident.' ' the approach chosen 
was to apply suspensions of guinea pig and human 
neutrophils to the complete coronary bed of isolated guinea 
pig hearts. perfused at physiological flow rates. This model 
also circunwents possible artefacts arising from alterations of 
endothelial cells during culture.' Another advantage concerns 
elaborating the site of action of adenosine. To date, only the 
effects of adenosine on neutrophils have been investigated: 
neglecting the possibility of endothelium mediated res- 
ponses. This is deemed to be of interest, because not only 
neutrophils' but also coronary endothelial cells possess both 
A, and A2 adenosine receptors.'* " Selective prestimulation 
of the coronary vascular endothelium can be readily 
achieved in the perfusion model, avoiding contact of the 
infused neutrophils with adenosine. 
The primary objectives of this study were: (1) to 
determine what effect adenosine has on neutrophil adhesion 
to coronary endothelium under shear stress conditions, with 
special consideration of the (patho)physiologically relevant 
concentrations of adenosine; (2) to characterise pharma- 
cologically and to localise the adenosine receptor (A,  v A2 
receptors; endothelium 11 neutrophil) responsible for a 
specific action; and (3) to investigate the consequences of 
ischaemia and preconditioning on neutrophil adhesion, 
defining the possible role of adenosine in both phenomena. 
The direct comparison of responses of guinea pig and human 
neutrophils served to elaborate the potential of the outlined 
perfusion model for investigating species differences in 
adhesion phenomena. 
hlethods 
Mute r i d s  
Human thrombin was purchased from Sigma. CPA (Nh-cyclo- 
penty ladenosine), DMPX (3,7-dimethyl- 1 -propargylxanthine), and 
DPCPX (dipropyl-8-cyclopentylxanthine) were obtained from Research 
Biochemicals. Iloprost was a gift from Schering AG, Berlin, Germany, 
Department of PhyGology. University of Munich. Pettenkoferstrasse 12, D-80336 Munich, Germany: S Zahler, B F Becker, 
P Raschke. E Gerlach. Correspondence to Dr Becker. 
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1367 Coronary endothelid adenosine receptors modulate neutrophil adhesion 
and adenosine came from Boehringer Mannheim. Percoll was 
purchased from Pharmacia. Hydroxy-ethyl starch (HES) was from 
Fresenius, and 18-’4C]adenosine from Amersham Buchler. All other 
chemicals, including the salts for the buffer solutions, were obtained 
from Merck. 
Isolution of neutrophils 
Human neutrophils were isolated from venous blood of healthy donors, 
guinea pig neutrophils from fresh arterial blood, drawn, in both cases, 
into polypropylene syringes containing 0.1 % EDTA (disodium 
ethylenediamine tetra-acetate) for anticoagulation. The blood was 
centrifuged for 15 min at 350 g and the platelet-rich plasma removed. 
The remaining cells were sedimented in 6% hydroxy-ethyl starch for 
75 rnin and the supernatant was centrifuged at 350 g for 10 min. The 
pellet was resuspended in phosphate buffered saline (PBS) containing 
0.1% EDTA and layered over Percoll (density 1.077 g.ml-’ for human 
cells and 1.082 for guinea pig neutrophils). After centrifugation at 
400 g for 25 min and washing, the residual erythrocytes were destroyed 
by hypotonic lysis with 5 ml distilled water at 4°C ( 1  and 2 min for 
human and guinea pig neutrophils, respectively). The neutrophils were 
washed in PBS, centrifuged, and finally resuspended in tris buffered 
Tyrode solution. Purity ( ~ 9 5 % )  and viability (>95%) of the cell 
preparation was routinely controlled by light microscopy (Pappenheim 
stain and Trypan blue exclusion test). The cell count was determined 
and adjusted to a number of 600000 neutrophilsm-’ buffer. This 
cell suspension was drawn into a polypropylene syringe (10 ml) 
immediately before the experiment. To determine neutrophil numbers 
in Tyrode solution and in samples of venous effluent (see below), cells 
were immediately counted in triplicate with a Coulter counter ZM. 
Though the cells obtained by this procedure cannot be regarded as 
completely unperturbed, they still presented uniformly excellent 
responses (chemiluminescence, aggre ation, and chemotaxis) to 
stimulation with a chemotactic peptide. 
Heart preparation and perjiusion 
Hearts of male guinea pigs (body weight 200-300 g, stunned by neck 
dislocation) were isolated and perfused as “Langendorff’ preparations 
at 37°C with a modified Krebs-Henseleit bicarbonate buffer, 
equilibrated with 94.4% O2 and 5.6% C 0 2  [pH 7.4 (SEM 0.02)]. The 
experimental details have been reported prev~ously.~~ The veins entering 
the right atrium were ligated, ensuring that the perfusate emerging from 
the coronary sinus passed through the pulmonary artery. The latter was 
cannulated to enable the collection of the coronary effluent. The 
perfusion pressure was continuously registered with a pressure 
transducer. 
Experimental protocol 
Experiments conformed with the Guide for the care and use of 
laboratory animals published by the US National Institutes of Health 
(NIH publication No 85-23, revised 198.5). 
A flow chart of the standard protocol is shown in fig 1. After the 
preparation and an initial period of 5 min of constant pressure perfusion 
at 60 mm Hg, the hearts were perfused at constant flow (5  mlmin-I) 
for 30 min. In experiments with DPCPX and DMPX, the substances 
were present in the perfusate from the onset of perfusion. For the 
treatment of hearts with thrombin, adenosine, CPA, or iloprost, 
respective stock solutions in isotonic saline were infused after the 30 
min into the aortic cannula at rates calculated to yield the desired end 
concentration in the coronary perfusate. These volumes never exceeded 
SO pl.min-’. After a further equilibration period of 5 min, a 1 ml bolus 
of the Tyrode solution containing the neutrophils was applied evenly 
over 1 min into the coronary system via the aortic cannula with an 
infusion pump, resulting in a flow of 6 rn1.min-l during the bolus. Thus 
about 100 000 neutrophils.ml-’ perfusate, or 600 000 neutrophils in total 
were infused. Coronary effluent was collected during the bolus and for 
15 
Bolus application (60 s) 
Sampling period (100 s )  
n 
n , 
f 
0 5 30 35 40 45 (rnin) 
Drug application 
- 7 -  - 
Constant Constant flow perfusion 
pressure 
perfusion 
Figure 1 Flow chart of a stundard experimental protocol. 
the following 40 s to quantify the number of neutrophils leaving the 
coronary system (neutrophil output). Pilot studies had shown that only 
a negligible number of cells (< 1 % )  ever emerged in the following 
5 rnin of perfusion. However, we have no knowledge as to whether the 
remaining cells were irreversibly retained or just severely retarded in 
washout. 
In each case, a test bolus of equal volume and duration ( I  nil. I niin) 
was sampled without coronary passage immediately before the 
intracoronary bolus to determine the number of cells actually leaving 
the syringe (neutrophil input). The percentage of neutrophils remaining 
adherent to the endothelium was then calculated as: 
[ l  - (outputhnput)] X 100 
To test the validity of our model, we assessed neutrophil adhesion in 
response to thrombin, a well characterised, rapidly acting (within 5 min) 
proadhesive agent.I4 We carried out these experiments with different 
neutrophil numbers (6 X lo5 to 7 X 10’ neutrophils per bolus) to 
establish whether percentual adhesion was influenced by the cell 
density. As this was not the case (n = 9, data not shown), we used the 
relatively low cell count of 6 X 10s per neutrophil bolus throughout our 
study. 
In one particular group of experiments, the adenosine infusion was 
stopped after 5 min and the adenosine was washed out for 1.5 min 
before the injection of neutrophils. Since the half time of adenosine 
washout was about 10 s (fig 2), this procedure avoided contact between 
infused cells and infused adenosine. 
In a further experimental set, neutrophils were incubated with 
1 )*M adenosine for 15 rnin prior to injection. The hearts to 
which these particular cells were applied received 0. I p.M adenosine 
starting 5 min before. The effective perfusate adenosine concentration 
during the neutrophil bolus therefore amounted to approximately 
0.26 pM. 
Myocardial ischaemia (global) was induced by interrupting perfusion 
for 15 min (zero flow) after the initial 30 rnin equilibration period. The 
temperature of the hearts was kept constant at 37°C during ischaemia 
by suspendin them in warm Tyrode buffer. After 1 rnin of reperfusion 
adenosine measurement were taken in I min intervals during the first 
5 min of reperfusion. 
Ischaemic preconditioning of the hearts was performed by 
interrupting coronary perfusion three times for 3 min, each ischaeniia 
being followed by a reperfusion period of 5 min. After the third 
reperfusion phase, the heart were subjected to a final global ischaemia 
of 15 min duration. Again, the temperature of the hearts was kept 
constant throughout the experiment. Application of the neutrophil bolus 
and adenosine sampling were carried out as described above. The time 
course of the preconditioning experiments is evident from fig 5.  
(at 5 ml.min- F ), the neutrophil bolus was injected. Effluent samples for 
Total counts 
(100% = 44 000 cpm.min-’.g-’) 
0.1% 
4 
14C-Adenosine 
0.01% 1 
1 / 1 1  I I I I I I I //-I 
0 1 2  4 6 8 10 12 14 16 20 25 30 
Washout (min) 
Figure 2 Coronary venous washout of “C-adenosine (0.1 pM, 
30 rnin labelling) from isolated perfused guinea pig hearts (one of 
three similar experiments). 
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Adenosine 111~~11.sirre1iie1n 
Quantification of adenosine in coronary effluent and in the supernatant 
of neutrophil suspensions \\ ;li performed by high perfomlance liquid 
chromatography (HPLC ). '4s dewribed prek iously." acidified samples 
(200 111) were applied directly to a C-18 nucleo\il column (Macherey- 
Napel, Diiren, Cermanq) and eluted M i t h  HCIO, (pH 2 )  usinp a 
methanol (60 v o l  % in H?O) gradient (0 t o  24q  in  20 inin). Retention 
time for adenosine was 20.4 inin. 
Kirreric~.~ qt atlenosini~ w t . s h o i i t  
To determine the half time of ,ideno\ine washout from the isolated 
heart\. [E-"C:]adenosine (specitic acti\it> 189 X 10"' Bq.lnol ' 1  \\as 
infused into the aortic cannula for -30 min at a concentration of 0.1 )*M. 
After cessation of infusion. coronary effluent \\;I\ continuously sampled 
in timed aliquot\ (see fig 21. Radioactivity i n  the corona0 venous 
effluent samples was measured in a 5cintlllation spectrometer usinp 
Rialuina (Baker. Deventer. Holland) as \cintillcation fluid. The 
radioactivity of the adenosine fraction obtained through HPLC 
! counted. The relativel!, constant rate of 
er\,ed after 5 min of the washout protocol 
e From prelnhelled adenine nucleotides of the 
Sftrri\ i ic~c/l  ln t ' f l lo t l s  
Each group i.on\istecl of tive experiment\. i f  not otherwise stated. 
The result\ iire $\en a s  mean(SEM). Statistical analysis  as per- 
formed with one \%a\ nnalysi\ of \ ariance ( .AM)\ . \ ) .  Whenever a 
ellect with ,\wrx\ \va\ ohtained. \\ e performed multiple 
e w e s  hctlveen Froups ivere considered 
tests between the groups using Student 
p 5 0.05. 
Results 
To test the ability of our model to detect changes in 
adhesivity. we first assessed neutrophil adhesion under 
control conditions and in response to  ;i 5 min application of 
thrombin (table I ) .  tinder control conditions, about 10% of 
the injected guinea pig neutrophils did not emerge from the 
perfused coronary system at the chosen rate of coronary 
flow. Thrombin caused a significant rise in adhesion of the 
homologous neutrophils of about SO% versus control. As 
shown in tig 3 and table 11. adenosine (0.1 p M ) .  infused into 
tem for 5 inin prior to and maintained during 
sion. enhanced adhesion of guinea pig 
neutrophils to  about the same extent as thrombin. 
To characterise the adenosine receptor involved in this 
effect pharmacologically. we applied the A ,  receptor agonist 
CPA (0.01 pM).  also for 5 min. and. i n  another series of 
experiments, adenosins (0.1 p M )  together with the A ,  
receptor antagonist DPCPX. The data in fig 3 show that CP,4 
is able t o  simulate the adenosine effect. whereas DPCPX 
completel> blocks i t .  DPCPX had no effect on adhesion 
[21(SEhil ?)(It retention] in the absence of exogenous 
adenosine. Thus the proadhesive effect of adenosine must 
clearly be mediated via the A ,  receptor subtype. 
Coronary effluent adenosine levels dropped to baseline 
within I min after cessation of arterial infusion (fig 2) .  
Washout experiments, i n  which the neutrophils were injected 
1.5 min after the end of a 5 min infusion of adenosine 
(0.1 pM). showed ful ly  sustained increases in retention 
Table I1 Emects of difereiit Lidenosine concentrations and of the 
A- receptor mttigoirisr 3.7-rli~nethyl-I -propargyl.xanthine (DMPX) 
o i l  irrlhererm~ of giiirieti pig iieiitrophils to homologous coronuq 
etitiotlieliiiin. Vc1rre.s cirr ntciiris(SEM). I I  = I0 in control group, 
I 1  = 5 i l l  thlJ Other gl~Oi1/7S. 
Control.' 
0.1 )*M Xdeno,ine 
0.3 )*M Adenosine 
I .O p M  Adenosine 
I .O pM .4denosine + 0. I W M  DMPX 
0.1 ~ L M  Adenos id l  ~ L M  adenosine (neutrophils) 
22(2.0) 
30( 1.4)* 
3 I (0.8)*' 
IC,(Z.Z) 
39(3.0)" 
32(2.0):1 
.Adenosine wiis infused into the coronary perfusatc for 5 min before and 
durins the neutrophil bolus. whereas DMPX was prewnt i n  the perfusate 
froni the onset of the heart preparation. In the last set of experiments. 
neutrophils were preincubated with I FM adenosine. and the hearts received 
onl! 0.1 pM adenosine. 
'> < 0.01 pM effluent adenosine. 
.:p<o.o5 1' contro1. 
(fig 3). Previous studies have shown that the intact endo- 
thelium is an efficient barrier for 0.1 p M  adenosine." I' 
Consequently, A,  receptors on the endothelial cells, and not 
those on the neutrophils or cardiac myocytes and vascular 
smooth muscle. must play the decisive role. 
Although thrombin is capable of inducing endothelial 
production of prostacyclin,l9 the prostaglandin I2 analogue 
iloprost did not alter neutrophil adhesion (table I). Since both 
iloprost and adenosine - via the A2 receptor'" - can enhance 
endothelial cell CAMP, this is further evidence favouring the 
involvement of A ,  adenosine receptors. The result obtained 
with iloprost also helps to rule out an indirect adenosine 
effect on adhesion by way of a dilatation induced reduction 
of intravascular shear stress or by an increase in coronary 
surface area. At the concentration applied (0.01 pM), 
iloprost reduced perfusion pressure to at least the same 
extent as adenosine (data not shown). This lowering of shear 
stress elicited no increase of neutrophil adhesion (table I). 
Furthermore. CPA enhanced adhesion without causing any 
drop in perfusion pressure 
40 
a, u
c 
E 
30 c 
-0 
iu 
r 
Cl 
- .- 
e 20 * 
3 
a, 
C 
a, 
a, 
c 
y 10 
a 
Control 
i 
ADO 
* 
ADO + 
DPCPX CPA ' ADO w a s h o u t  * 
Figure 3 A ,  receptor niedicited tiction of adenosine on adhesion 
of giiirieii p i g  rieiitrophils to ivr-oiian endothelium. Adhesion is 
s h o w i  i i r i i k v -  the iiEfliience of acleriosirie (0.1 pM), of tritenosine in 
tlie pwserlce of the A l  receptor- antagonist dipropyl-8-cylo- 
I-".tihl.~.iiritllitie (DPCPX. 0. I p M ) ,  and of the A ,  receptor agonist 
~-c~clopentyliick.r,osine (CPA, 0.01 p M ) .  A ,  mediated effects on 
the neirtrophils were escliiderl by the w-ashout protocol: neutrophils 
n'ere injected 1.5 inin arfter cessation of adenosine infu.sion. Vulues 
iire i i i e m s  of ,five iy'eriineizts each: error birrs = SEM. 
':'p < 0.05 v control. 
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- 
Interestingly, the proadhesive effect of adenosine showed 
a bell shaped concentration dependence with a maximum in 
the range of 0.1-0.3 p,M (table 11). At 1 p M  adenosine, 
adhesion was again reduced to the control level. However, 
if the A, receptor antagonist DMPX (0.1 pM) was co-infused 
with 1 p,M adenosine, adhesion was further stimulated, 
increasing to 39(3)% (table 11). DMPX alone did not 
influence neutrophil adhesion (results not shown). When 
neutrophils were incubated with 1 pM adenosine for 15 min 
prior to infusion into hearts that had received 0.1 p M  
adenosine according to the standard protocol, adhesion was 
not reduced in comparison to untreated neutrophils (table 11). 
Therefore, the adhesion reducing A2 receptors have to be 
located on the endothelium. 
Subjecting the isolated hearts to global normothermic 
ischaemia of 15 min duration augmented subsequent 
adhesion of neutrophils, an effect that could be fully blocked 
by the Al receptor antagonist DPCPX (fig 4). Pre- 
conditioning the hearts with three short ischaemic periods of 
3 min each had quantitatively the same protective effect as 
A, receptor blockade (fig 4). 
In the experiments without preconditioning, postischaemic 
adenosine levels in the venous effluent were initially 0.8 p,M 
and, at the time of neutrophil injection, about 0.45 p,M 
(fig 5). After preconditioning, the adenosine values were 
notably higher, initially about 1.5 pM and still in the order 
of 0.6 pM during the bolus (fig 5). 
To test the hypothesis that repetitive stimulation of A, 
receptors by preconditioning might lead to short term 
tachyphylaxis and therefore to cessation of the proadhesive 
effect, adenosine (0.1 p,M) was continuously infused over 
30 min. Since adhesion remained enhanced [30(7)%], this 
possibility was ruled out. 
Finally, fig 6 shows that when human neutrophils were 
injected, control adhesion, as well as thrombin or adenosine 
stimulated adhesion, was nearly identical to the respective 
values obtained for guinea pig neutrophils. 
I 
I Control lschaemia lschaernia + lschaernia + 
DPCPX Drecondi- * tioning T 
T 
Figure 4 Effect of 15 min of normothermic global ischaemia on 
the adhesion of guinea pig neutrophils to homologous coronary 
endothelium. The enhanced adhesion after ischaemia was fully 
prevented by applying the A ,  receptor antagonist dipropyl- 
8-cyclopentylxanthine (DPCPX, 0.1 pM) throughout the experiment 
or by preconditioning with three short (3  min) ischaemic periods, 
each followed by 5 min of reperfusion. Values are means of jive 
experiments each; error bars = SEM. 
*p < 0.05 v control. 
c 
E 1000 
a, 
lschaernia (15 rnin) after 
preconditioning (3 x 3 rnin 
ischaernia) I 
0 10 20 30 40 
Time (rnin) 
Figure 5 Adenosine concentrations in the venous coronary 
efluent of isolated guinea pig hearts subjected to 15 min of global 
normothermic ischaemia. The postischaemic adenosine release w a s  
sign$cantly enhanced by preconditioning with three ischaemic 
intervals, each of 3 min duration. The arrows indicate the time cf 
injection (second minute of reperfusion) of the neutrophils (600 000 
cells in a bolus). Error bars indicate SEM where graphical 
resolution is possible. Filled triangle: n = 3, no injection of 
neutrophils, jilled circle: n = 7, no injection of neutrophils; all other 
experiments n = 5. 
*p < 0.05 v ischaemia. 
40 
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Figure 6 
Control Thrombin Adenosine 
* 
T 
* 
-k 
Effect of the proadhesive agent thrombin (0.3 U.mt') 
and of adenosine (0.1 p M )  on the adhesion of human neutrophils 
to guinea pig coronary vasculature. Neutrophils were infused as a 
1 ml bolus of 600 000 cells into the c0ronar.y perfusate of isolated 
guinea pig hearts. Non-adherent neutrophils were subsequently 
determined in the coronary efluent. Adhesion is expressed as 
percentage of cells not leaving the coronaty system within 100 s 
after bolus onset. Values are means, error bars=SEM, of five 
experiments each. 
*p < 0.05 v control. 
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Discussion 
Several papers have been published concerning beneficial 
effects of adenosine on inflammatory processes in general.’ 
on the extent of reperfusion injury.‘ and especially on a 
participation. via A ,  receptors, in the phenomenon of 
ischaemic preconditioning.” ” On the other hand. we have 
previously shown that endogenous adenosine (0.1-0.2 p M )  
contributes to postischaemic reperfusion injury mediated by 
neutrophils in an isolated guinea pig heart model. and that 
this too depends on adenosine A, receptors.’ According to the 
results obtained in the present study. adenosine (0.1-0.3 p M )  
induces adhesion of guinea pig as well us of human 
neutrophils to  the intact coronary system of guinea pig hearts 
by acting o n  endothelial A ,  receptors. This proadhesive 
effect provides a basis for a deleterious action of adenosine. 
although we do not know the ultimate fate of the cells. that 
is. whether they emigrate into the tissue or are protractedly 
washed o u t .  
The tinding that adenosine can enhance neutrophil adhesion 
via A, receptors corresponds to some results of Cronstein and 
coworkers.” However. there seem to be differences concerning 
the underlying mechanisms. First. Cronstein‘s group relates 
its findings to an effect of adenosine on the neutrophil, 
whereas we demonstrate an effect elicited on the endothelium. 
Second. Cronstein’s studies pertain to effects occurring when 
neutrophils were stimulated by a chemotactic peptide. in 
contrast LO our investigation using relatively unperturbed 
neutrophils. Third. we examined neutrophil adhesion under 
physiological shear stress, and not in quiescent culture dishes. 
Although species differences could also be involved in 
causing divergent results, there may well be several distinct 
ways of modulating neutrophil attachment to endothelial cells 
with adenosine. This could occur either via the previously 
described A! and A? receptors on neutrophils.” or via endo- 
thelial A, and A? receptors. guinea pig coronary endothelial 
cells being known to possess both types. I“ ‘ I  
In our model. the proadhesive effect vanished at a high 
adenosine concentration ( 1 pM). However. I p M  adenosine 
further enhanced adhesion if applied in  the presence of the 
A2 antagonist DMPX (table 11). Although DMPX is not 
absolutely selective for A2 receptors. a submaximal concen- 
tration (0.1 kM)  was applied, that is. one which significantly 
but not completely reduced coronary dilatation elicited by 
I k M  adenosine via A: receptor mechanisms (drop in coronary 
perfusion pressure 14( 1 ) and 2 3 2 )  mm Hg, with and without 
DMPX. respectively ). At such a low concentration. receptor 
specificity of DMPX should be largely guaranteed. The 
suppression of adhesion by 1 p M  adenosine thus reflects the 
onset of inhibitory A2 actions’ ’’ and complies with the fact 
that A? receptors have a lower affinity for adenosine than A, 
receptors.” At tirst we assumed the responsible A, 
mechanisms to be those familiar in the neutrophil but. again. 
the endothelium proved to be the principal site of action: 
experiments involving pre-exposure of the neutrophil to 
micromolar concentrations of adenosine. while the endo- 
thelium was only confronted with low levels (0.26 pM), 
showed retention of  the pro-adhesive action. Thus endo- 
thelial A , and A? receptors exert mutually antagonistic effects 
on neutrophil adhesion. Although the adhesion of neutrophils 
can clearly be selectively regulated by adenosine A, and A’ 
receptors, the receptor subtype specific mechanisms of the 
endothelium still remain to be characterised. Synergism with 
the respective A ,  and A2 receptor actions on the neutrophil 
s e e m  possible. The concept of a concentration dependent 
bimodal action of adenosine is additionally supported by the 
finding that the proadhesive effect of 15 minutes of global 
ischaemia, caused via the A, receptor and associated with 
coronary effluent adenosine levels in the submicromolar 
range. was notably attenuated by preconditioning (fig 4), an 
intervention which lead to even higher postischaemic 
adenosine concentrations (initially > 1 pM). Because the A: 
receptor mediated inhibition of adhesion was evoked at the 
endothelium in our model, it should be these initial values 
which set the stage for responsiveness towards subsequently 
applied neutrophils. Pertinantly. enhancement of adenosine 
release from ischaemic hearts after preconditioning has 
already been described in a different model.” An alternative 
explanation for the effect of preconditioning on adhesion, 
namely desensitisation of the A, receptor, seems unlikely 
during short term ischaemia and preconditioning, there being 
no evidence for tachyphylaxis of the A, response following 
sustained (30 min) exposure of the endothelium to 
moderately elevated adenosine (0.1 pM). 
The discrepant results concerning the role of adenosine in 
adhesion and in reperfusion injury (see, for example, 
references 3.9, 18, and 19 as opposed to 7 and 9) most likely 
arise from the range of adenosine concentrations employed, 
and therefore the receptor subtype engaged. Though 
adenosine at high concentrations inhibits various functions of 
neutrophils (aggregation,’” radical production”), these 
responses remain unaffected in both guinea pig and human 
neutrophils at adenosine concentrations below 1 kM.” 
Similarly, in studies reporting inhibition of adhesion of 
neutrophils by adenosine, either adenosine analogues of 
higher potency and lower metabolic turnover than the 
physiological agent were applied at extreme levels of 10 to 
200 pM,‘ ” or adenosine itself was used in concentrations 
> 9  pM.’ In vivo, however, adenosine concentrations in 
arterial and coronary sinus blood under basal conditions have 
been found to be about 0.08 kM.’” In blood leaving hearts 
subjected to PTCA or pacing induced ischaemia, adenosine 
levels are in the order of 0.1 to 1 F M . ~  ’ In the context of 
concentration dependency, it is also interesting to note that, 
in  our present study, the adenosine concentrations i n  the 
postischaemic venous effluent of individual hearts at the 
onset of reperfusion (0.6-2.0 pM) and the respective degree 
of neutrophil adhesion correlated negatively (adhesion= 
35-0.0065 X (adenosine], regression coefficient 0.5). 
There is another reason why most in vitro studies which 
have examined adenosine effects on neutrophils to date 
reflect more a scenario of pharmacological intervention than 
of postischaemic reperfusion. This is because the neutrophils 
were consistently incubated with high concentrations of 
adenosine.‘ ’ 27 After an ischaemic insult, however, the 
adenosine concentration is only locally elevated, not 
systemically, due to rapid elimination of adenosine from 
plasma by vascular endothelium and red blood cells. There- 
fore, the endothelial cells and the few resident neutrophils 
within an ischaemic vessel may be “incubated’ with raised 
adenosine concentrations, but not the circulating neutrophils 
that reach the infarcted area only during reperfusion. The 
same objection pertains to in vivo models in  which 
adenosine was systemically applied.’” 
Certain characteristics of the adhesion model described 
here bear mentioning. The basal adhesion of 20% seems 
rather high and may reflect a certain degree of prestimulation 
of both the endothelial cells and the neutrophils. However, 
lower values were obtainable if shear stress was raised by 
increasing the coronary How (unpublished results). More- 
over. approximately similar values of basal adhesion” .” as 
well as rite of onset and extent of stimulation with 
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thrombini4 have been obtained in studies with cultured 
endothelium. Furthermore, we have no knowledge, so far, 
concerning the ultimate fate of the retained or retarded cells: 
the counting procedure gives a relatively rapid resolution, 
but does not directly yield long term insights. 
The nature of both the endothelial and neutrophil localised 
adhesion molecules involved in the A, receptor effect 
reported here remains to be clarified. Thrombin has been 
shown to cause rapid induction (within five minutes) of shear 
stress resistant adhesion to cultured endothelial cells via 
externalisation of endothelial P  electi in.^^ However, we have 
previously shown that guinea pig P selectin does not interact 
with human ne~trophils. '~ The characteristics of the adhesion 
induced by adenosine (rapid, resistant to shear stress), 
indicate that in this case too a preformed adhesion molecule 
other than P selectin (perhaps a ligand for L  electi in'^) might 
be externalised to the endothelial cell surface. As 
intracoronary adhesion of human and guinea pig neutrophils 
responded to adenosine in exactly the same way, a species 
difference regarding the respective adhesion partner on the 
granulocytes seems unlikely. 
In the face of the present results, it is difficult to explain 
why preconditioning in some animal models depends on A, 
receptor activation." ** Of course, the proadhesive effect of 
adenosine may be unique to guinea pig coronary endo- 
thelium. However, the benefit of Al receptor stimulation in 
the pertinant studies was determined without allowing for 
possible systemic actions of the applied agonists or antago- 
nists with respect to neutrophil adhesion. Thus simulation of 
cardiac preconditioning by intravenous application of A,  
receptor agonists'* could evolve from acute neutropenia 
resulting from systemically stimulated neutrophil adhesion. 
Although it is not yet clear whether human coronary 
endothelial cells also possess A, receptors, it is, nevertheless, 
appealing to relate the present findings to reperfusion of the 
human heart. At submicromolar concentrations (presumably 
relevant in reperfused myocardial tissue in man), the A, 
effect described here would cause adhesion of neutrophils to 
increase, thereby setting the stage for further neutrophil 
mediated tissue damage. Therefore, adenosine perhaps 
should not be expected to act as a cardioprotective agent7 
under all circumstances, and Al antagonists may well exert 
beneficial effects in the reperfused heart in vivo, as already 
shown in ~ i t r o . ~  Conversely, it may be speculated that the 
beneficial use of high adenosine concentrations or substances 
that enhance endogenous adenosine levels sufficiently is in 
part due to the antiadhesive effect of endothelial A2 receptor 
stimulation. In this case A2 receptor blocking drugs would be 
potentially deleterious. Finally, the protective effect of 
preconditioning may be partly caused by increasing 
adenosine levels into the cardioprotective range.25 
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